Klinische Studie

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

NCT: NCT05743842 · ACTIVE_NOT_RECRUITING

NCT-IDNCT05743842

Medizinische Daten: StatusACTIVE_NOT_RECRUITING

Startdatum2023-03-14

Abschluss2027-12-31

SponsorM.D. Anderson Cancer Center (OTHER)

First posted2023-02-24

Last updated2026-09-16

Kurzzusammenfassung

To learn if using the TriNav Infusion System (TriNav catheter) for the injection of the surrogate/test dose during the planning part of the radioembolization procedure and your actual treatment with the radioactive microspheres match each other better than the standard catheter.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.